Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer Dosing

Clinical trial NCT00324376 · COMPLETED

Trial details

NCT number: NCT00324376
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Kidney Disease

Start date: 2003-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.